The Boston-Cambridge area is home to a large research community of diverse scientists studying Type I and Type II diabetes. At present, many investigators are attempting to carry out techniques in their own laboratories for research goals that in many cases are no longer their primary area of specialty. This is particularly true for flow cytometry and complex separations of lymphocytes with the need for tight controls on the quality of the preparations. Importantly, few flow cytometry cores are dedicated to investigators involved in diabetes research. The purpose of this Immunology Core of the Boston Area Diabetes Endocrinology Research Center (BADERC) is to financially improve and scientifically expedite the translation of excellent ongoing diabetes research through a cost efficient mechanism. This has been successfully accomplished by the Immunology Core, which has been highly utilized over the past 5 years. The Immunology Core has provided strong education to investigators and a diversity of state-of-the-art flow cytometric techniques and new robotic methods for lymphocyte separations. Remarkably, at the entire Massachusetts General Hospital, Harvard Medical School as well as Boston University no flow cytometry core for diabetes users and collaborators and for their applications central to Type 1 and Type II diabetes research existed prior to the BADERC. The Immunology Flow Cytometry Core has provided these fundamental services to the Boston-Cambridge diabetes based research community including: .Flow cytometer access, data preparation and interpretations .Flow cytometry training, education and experiment design assistance. .Flow cytometry sample analysis with sorting, multi-color detection, fluorchrome labeling, antibody purifications, DNA and Ca flux experiments, etc. .Manual and robotic human blood lymphocyte separations for standardizations of assays using robotics. These Center services have been very cost effective as well as to provide rigorous training in Immunology.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-2)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Kim, MiSung; Astapova, Inna I; Flier, Sarah N et al. (2017) Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight 2:
Mumtaz, Rizwan; Trepiccione, Francesco; Hennings, J Christopher et al. (2017) Intercalated Cell Depletion and Vacuolar H+-ATPase Mistargeting in an Ae1 R607H Knockin Model. J Am Soc Nephrol 28:1507-1520
Palmer, Colin J; Bruckner, Raphael J; Paulo, Joao A et al. (2017) Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue. Mol Metab 6:1212-1225
Dai, Ning; Ji, Fei; Wright, Jason et al. (2017) IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1. Elife 6:
Fenselau, Henning; Campbell, John N; Verstegen, Anne M J et al. (2017) A rapidly acting glutamatergic ARC?PVH satiety circuit postsynaptically regulated by ?-MSH. Nat Neurosci 20:42-51
Kitano, Kentaro; Schwartz, Dana M; Zhou, Haiyang et al. (2017) Bioengineering of functional human induced pluripotent stem cell-derived intestinal grafts. Nat Commun 8:765
Li, Wei; Jin, William W; Tsuji, Kenji et al. (2017) Ezrin directly interacts with AQP2 and promotes its endocytosis. J Cell Sci 130:2914-2925
Cheng, Longzhen; Duan, Bo; Huang, Tianwen et al. (2017) Identification of spinal circuits involved in touch-evoked dynamic mechanical pain. Nat Neurosci 20:804-814
Fisher, Ffolliott M; Kim, MiSung; Doridot, Ludivine et al. (2017) A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Mol Metab 6:14-21
Campbell, John N; Macosko, Evan Z; Fenselau, Henning et al. (2017) A molecular census of arcuate hypothalamus and median eminence cell types. Nat Neurosci 20:484-496

Showing the most recent 10 out of 372 publications